Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Invivo Therapeutics Holdings Corp Company Profile (NASDAQ:NVIV)

Consensus Ratings for Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.00 (191.26% upside)

Analysts' Ratings History for Invivo Therapeutics Holdings Corp (NASDAQ:NVIV)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/25/2013AegisLower Price TargetBuy$7.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
8/27/2013ZacksReiterated RatingNeutral -> Neutral$2.00ViewTweet This Rating  Share This Rating on StockTwits
8/23/2013AegisBoost Price TargetBuy$6.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
3/14/2013ZacksReiterated RatingOutperform -> Outperform$5.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2012AegisInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/22/2012 forward)